Related Experiment Video
Updated: Sep 3, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Recent advances in the management of lung and breast cancer. Future directions
1Arizona Cancer Center, University of Arizona College of Medicine, Tucson 85724.
Abstract:
Since mortality from breast cancer remains unacceptably high, hopes for future treatment depend, in large part, on the development of pharmacologic interventions based on an increased understanding of the biology of cancer. A fruitful area of exploration may be that of antisense RNAs which may inhibit the expression of a given growth factor or a given cellular product. It is also possible that an antisense RNA can be developed that will inhibit the production of proteins responsible for drug resistance. Another potential approach is the use of the Her-2-Neu oncogene cell membrane protein target for monoclonal antibody radioimmunoconjugates for therapy. Finally, since low-fat, reduced-calorie diets are considered an important part of preventive programs, the use of artificial fats may also make a significant difference in changing life-style habits.
Insights
Future breast cancer treatments may involve novel pharmacologic interventions. These include antisense RNAs to inhibit growth factors or drug resistance, and Her-2-Neu targeted therapies, alongside lifestyle changes with artificial fats.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Breast cancer mortality remains high, necessitating innovative treatment strategies.
- Understanding cancer biology is crucial for developing effective pharmacologic interventions.
- Current preventive programs emphasize diet, suggesting lifestyle modifications are key.
Purpose of the Study:
- To explore novel therapeutic strategies for breast cancer.
- To investigate the potential of antisense RNAs in cancer treatment.
- To evaluate targeted therapies and lifestyle interventions for breast cancer.
Main Methods:
- Exploration of antisense RNA technology to inhibit specific gene expression.
- Development of monoclonal antibody radioimmunoconjugates targeting the Her-2-Neu oncogene.
- Consideration of dietary interventions, including artificial fats, for lifestyle modification.
Main Results:
- Antisense RNAs show promise in inhibiting growth factors and cellular products.
- Antisense RNAs may overcome drug resistance by inhibiting relevant protein production.
- Her-2-Neu targeted therapies offer a potential treatment avenue.
- Artificial fats could aid in adopting healthier, low-fat diets.
Conclusions:
- Antisense RNA technology presents a promising avenue for breast cancer pharmacologic intervention.
- Targeting the Her-2-Neu oncogene with radioimmunoconjugates is a viable therapeutic strategy.
- Dietary modifications, including the use of artificial fats, can support breast cancer prevention efforts.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Survival Analysis

